[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-001", "question": "A 48-year-old woman with a history of systemic lupus erythematosus (SLE) on hydroxychloroquine and low-dose prednisone presents with 3 weeks of progressive dyspnea on exertion and dry cough. High-resolution CT shows diffuse ground-glass opacities with superimposed fine reticulation and subpleural sparing. Bronchoalveolar lavage reveals lymphocytic predominance (65%) with CD4:CD8 ratio of 0.8. Pulmonary function tests show a restrictive pattern with severely reduced DLCO (38% predicted). Which of the following is the most appropriate next step in management?", "options": ["Initiate high-dose intravenous methylprednisolone followed by oral prednisone 1 mg/kg/day", "Add mycophenolate mofetil to current immunosuppression", "Discontinue hydroxychloroquine and observe for 4 weeks", "Perform surgical lung biopsy to confirm usual interstitial pneumonia pattern", "Start rituximab therapy without additional testing"], "answer": "B", "answer_index": 1, "explanation": "The presentation is classic for lymphocytic interstitial pneumonia (LIP) associated with SLE, characterized by ground-glass opacities with reticulation, lymphocytic BAL, and low CD4:CD8 ratio. LIP in connective tissue disease typically requires more aggressive immunosuppression beyond steroids alone. Mycophenolate mofetil is the preferred steroid-sparing agent for SLE-associated interstitial lung disease with this pattern. High-dose steroids alone (A) are insufficient for progressive LIP. Hydroxychloroquine cessation (C) is unlikely to reverse established ILD. Surgical biopsy (D) is unnecessary with characteristic HRCT and BAL findings. Rituximab (E) is reserved for refractory cases after conventional immunosuppression fails.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes Non-Specific Interstitial Pneumonia (NSIP), indicated by ground-glass opacities with 'subpleural sparing,' which is the radiologic hallmark of NSIP. The provided rationale incorrectly identifies the diagnosis as Lymphocytic Interstitial Pneumonia (LIP), which typically presents with thin-walled cysts and centrilobular nodules, not subpleural sparing. Despite this diagnostic error in the author's explanation, the Keyed Answer (B, Add mycophenolate mofetil) is the correct standard-of-care management for SLE-associated NSIP. Regarding the distractors: Option A (High-dose steroids) is clinically tempting given the severe impairment (DLCO 38%) and progressive symptoms, as MMF is slow-acting and immediate steroid induction is standard. However, in board-exam contexts, the specific disease-modifying agent (MMF) is often the intended answer over generic steroid rescue, and Option A implies a taper to steroid monotherapy, which is insufficient for maintenance. Thus, the item is logically valid because the vignette findings (NSIP) map to the correct therapeutic key (MMF), despite the rationale's nomenclature error.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes Non-Specific Interstitial Pneumonia (NSIP), indicated by ground-glass opacities with 'subpleural sparing,' which is the radiologic hallmark of NSIP. The provided rationale incorrectly identifies the diagnosis as Lymphocytic Interstitial Pneumonia (LIP), which typically presents with thin-walled cysts and centrilobular nodules, not subpleural sparing. Despite this diagnostic error in the author's explanation, the Keyed Answer (B, Add mycophenolate mofetil) is the correct standard-of-care management for SLE-associated NSIP. Regarding the distractors: Option A (High-dose steroids) is clinically tempting given the severe impairment (DLCO 38%) and progressive symptoms, as MMF is slow-acting and immediate steroid induction is standard. However, in board-exam contexts, the specific disease-modifying agent (MMF) is often the intended answer over generic steroid rescue, and Option A implies a taper to steroid monotherapy, which is insufficient for maintenance. Thus, the item is logically valid because the vignette findings (NSIP) map to the correct therapeutic key (MMF), despite the rationale's nomenclature error.", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-002", "question": "A 62-year-old man with metastatic renal cell carcinoma on nivolumab and ipilimumab presents with acute-onset diplopia, ptosis, and dysphagia 6 weeks after initiation. Neurological exam reveals bilateral asymmetric ophthalmoparesis, fatigable ptosis, proximal muscle weakness, and normal pupillary responses. Repetitive nerve stimulation shows 25% decrement at 3Hz. Which of the following is the most specific diagnostic test to confirm the underlying pathophysiology?", "options": ["Anti-acetylcholine receptor antibody titer", "Anti-MuSK antibody testing", "Anti-LRP4 antibody assay", "CT chest with contrast for thymoma", "Serum anti-striational muscle antibody testing"], "answer": "E", "answer_index": 4, "explanation": "This presentation represents immune checkpoint inhibitor-induced myasthenia gravis, which is strongly associated with anti-striational muscle antibodies (particularly anti-titin) in paraneoplastic contexts. While anti-AChR antibodies (A) are positive in most generalized MG, anti-striational antibodies have higher specificity for thymoma-associated and paraneoplastic MG in cancer patients on immunotherapy. Anti-MuSK (B) and anti-LRP4 (C) antibodies are associated with different MG subtypes but not specifically with paraneoplastic forms. CT for thymoma (D) is indicated but not the most specific test for pathophysiology. The combination of immune checkpoint therapy with these neurological findings makes anti-striational antibodies the key diagnostic marker.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with immune checkpoint inhibitor-associated myasthenia gravis (ICI-MG), evidenced by ocular/bulbar weakness, fatigability, and decremental response on repetitive nerve stimulation. The standard diagnostic test to confirm the pathophysiology of myasthenia gravis (neuromuscular junction blockade) is the anti-acetylcholine receptor (AChR) antibody titer (Option A). Anti-AChR antibodies are positive in approximately 60–70% of ICI-MG cases and are the direct cause of the pathology. While anti-striational antibodies (Option E) are often present in ICI-MG (particularly with concurrent myositis or thymoma) and are markers of a paraneoplastic etiology, they are not the primary test to confirm the neuromuscular transmission defect itself. The provided explanation conflates 'marker of paraneoplastic context' with 'diagnostic test for pathophysiology.' Since Option A is the standard, most specific test for the mechanism of the patient's symptoms (MG), and Option E is a secondary marker, the item is miskeyed. The correct best answer is A.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with immune checkpoint inhibitor-associated myasthenia gravis (ICI-MG), evidenced by ocular/bulbar weakness, fatigability, and decremental response on repetitive nerve stimulation. The standard diagnostic test to confirm the pathophysiology of myasthenia gravis (neuromuscular junction blockade) is the anti-acetylcholine receptor (AChR) antibody titer (Option A). Anti-AChR antibodies are positive in approximately 60–70% of ICI-MG cases and are the direct cause of the pathology. While anti-striational antibodies (Option E) are often present in ICI-MG (particularly with concurrent myositis or thymoma) and are markers of a paraneoplastic etiology, they are not the primary test to confirm the neuromuscular transmission defect itself. The provided explanation conflates 'marker of paraneoplastic context' with 'diagnostic test for pathophysiology.' Since Option A is the standard, most specific test for the mechanism of the patient's symptoms (MG), and Option E is a secondary marker, the item is miskeyed. The correct best answer is A.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-003", "question": "A 34-year-old pregnant woman at 32 weeks gestation presents with acute-onset severe headache, photophobia, and confusion. BP is 150/95 mmHg. MRI brain shows bilateral cortical and subcortical edema predominantly in posterior parietal and occipital lobes, with patchy cortical diffusion restriction. MR venography is normal. She has no proteinuria. Which of the following is the most likely underlying vascular pathophysiology?", "options": ["Cerebral venous sinus thrombosis", "Posterior reversible encephalopathy syndrome", "Reversible cerebral vasoconstriction syndrome", "Eclampsia without hypertension", "Posterior circulation ischemic stroke"], "answer": "C", "answer_index": 2, "explanation": "This represents reversible cerebral vasoconstriction syndrome (RCVS) in pregnancy, characterized by thunderclap headache, normal venography, and posterior-predominant edema with diffusion restriction. The key distinction from PRES (B) is the presence of cortical diffusion restriction and more severe headache. RCVS involves segmental cerebral arterial vasoconstriction rather than hypertensive breakthrough autoregulation. Cerebral venous thrombosis (A) would show venous occlusion. Eclampsia (D) typically requires significant hypertension and proteinuria. Posterior circulation stroke (E) would show more defined arterial territory infarction rather than patchy cortical involvement.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of Posterior Reversible Encephalopathy Syndrome (PRES): a pregnant patient with acute hypertension (150/95 mmHg is elevated enough in pregnancy to overwhelm autoregulation), neurological symptoms (headache, confusion, visual changes), and the pathognomonic MRI finding of bilateral posterior cortical/subcortical edema. The provided Key (C, RCVS) is incorrect. While RCVS and PRES can overlap, the imaging findings described (posterior-predominant edema) are the diagnostic definition of PRES. The author's rationale relies on the medically inaccurate premise that cortical diffusion restriction excludes PRES; in reality, patchy diffusion restriction (cytotoxic edema) is a well-documented feature in 15–30% of PRES cases ('malignant PRES'). Furthermore, RCVS is defined by segmental vasoconstriction on angiography, which is not mentioned, whereas the MRI findings provided are sufficient to diagnose PRES (Option B). Therefore, Option B is the unique best answer supported by the text, making the item miskeyed.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of Posterior Reversible Encephalopathy Syndrome (PRES): a pregnant patient with acute hypertension (150/95 mmHg is elevated enough in pregnancy to overwhelm autoregulation), neurological symptoms (headache, confusion, visual changes), and the pathognomonic MRI finding of bilateral posterior cortical/subcortical edema. The provided Key (C, RCVS) is incorrect. While RCVS and PRES can overlap, the imaging findings described (posterior-predominant edema) are the diagnostic definition of PRES. The author's rationale relies on the medically inaccurate premise that cortical diffusion restriction excludes PRES; in reality, patchy diffusion restriction (cytotoxic edema) is a well-documented feature in 15–30% of PRES cases ('malignant PRES'). Furthermore, RCVS is defined by segmental vasoconstriction on angiography, which is not mentioned, whereas the MRI findings provided are sufficient to diagnose PRES (Option B). Therefore, Option B is the unique best answer supported by the text, making the item miskeyed.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-004", "question": "A 57-year-old man with alcoholic cirrhosis (Child-Pugh B) presents with fever, abdominal pain, and altered mental status. Paracentesis reveals ascitic fluid with 450 neutrophils/mm³. Blood and ascitic fluid cultures grow extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. He receives meropenem for 72 hours but remains febrile with worsening encephalopathy. Repeat paracentesis shows 520 neutrophils/mm³ with negative cultures. Which of the following is the most appropriate next step?", "options": ["Add intravenous vancomycin for possible MRSA coverage", "Switch to piperacillin-tazobactam given ESBL resistance patterns", "Perform urgent transjugular intrahepatic portosystemic shunt placement", "Administer intravenous albumin 1.5 g/kg on day 1 and 1.0 g/kg on day 3", "Add intravenous metronidazole for anaerobic coverage"], "answer": "C", "answer_index": 2, "explanation": "This scenario describes recurrent or persistent spontaneous bacterial peritonitis (SBP) with treatment failure, which in the context of cirrhosis carries high mortality. TIPS placement reduces portal pressure and may improve outcomes in refractory SBP by decreasing bacterial translocation. Albumin (D) is indicated for SBP but already should have been given initially. Antibiotic changes (A, B, E) are inappropriate with negative repeat cultures and clinical deterioration despite appropriate initial therapy. In refractory SBP with ongoing inflammation despite adequate antibiotics, TIPS can be life-saving by addressing the underlying pathophysiology of portal hypertension.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N (No answer defensible). Verdict on keyed answer: Dangerous/Contraindicated. The patient presents with SBP treatment failure (rising neutrophils despite carbapenem) and worsening hepatic encephalopathy (HE). The keyed answer (C, Urgent TIPS) is medically unsound and typically contraindicated in this scenario. TIPS is well-established to worsen hepatic encephalopathy; performing it in a patient with worsening HE is dangerous. Additionally, TIPS is generally contraindicated during active, uncontrolled systemic sepsis due to the risk of stent infection (endotipsitis) and precipitating liver failure. The rationale conflates the role of TIPS in preventing recurrence or managing refractory ascites with acute rescue of septic treatment failure. Standard management for SBP non-response involves evaluating for secondary peritonitis (CT scan) or broadening antimicrobial coverage (e.g., for fungal or resistant Gram-positive organisms). Option D (Albumin) is indicated on Day 3 but is supportive and does not address the infection failure. Option A is empiric but low yield given negative cultures. Since the keyed answer is contraindicated and no other option addresses the primary problem (treatment failure) appropriately, no answer is defensible.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (No answer defensible). Verdict on keyed answer: Dangerous/Contraindicated. The patient presents with SBP treatment failure (rising neutrophils despite carbapenem) and worsening hepatic encephalopathy (HE). The keyed answer (C, Urgent TIPS) is medically unsound and typically contraindicated in this scenario. TIPS is well-established to worsen hepatic encephalopathy; performing it in a patient with worsening HE is dangerous. Additionally, TIPS is generally contraindicated during active, uncontrolled systemic sepsis due to the risk of stent infection (endotipsitis) and precipitating liver failure. The rationale conflates the role of TIPS in preventing recurrence or managing refractory ascites with acute rescue of septic treatment failure. Standard management for SBP non-response involves evaluating for secondary peritonitis (CT scan) or broadening antimicrobial coverage (e.g., for fungal or resistant Gram-positive organisms). Option D (Albumin) is indicated on Day 3 but is supportive and does not address the infection failure. Option A is empiric but low yield given negative cultures. Since the keyed answer is contraindicated and no other option addresses the primary problem (treatment failure) appropriately, no answer is defensible.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-005", "question": "A 41-year-old woman with antiphospholipid syndrome (triple positive) on warfarin (INR 2.8) presents with acute right hemiparesis and aphasia. CT angiogram shows complete occlusion of the left middle cerebral artery M1 segment. She is 4 hours from symptom onset. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator", "Proceed with mechanical thrombectomy without thrombolysis", "Give intravenous heparin bolus followed by infusion", "Administer intra-arterial thrombolysis via catheter", "Continue warfarin and add aspirin 325 mg"], "answer": "B", "answer_index": 1, "explanation": "In antiphospholipid syndrome with acute large vessel occlusion, mechanical thrombectomy is indicated regardless of anticoagulation status. tPA (A) is contraindicated with therapeutic INR >1.7. Heparin (C) adds bleeding risk without proven benefit in acute stroke with therapeutic anticoagulation. Intra-arterial thrombolysis (D) carries similar bleeding risks as IV tPA. Continuing warfarin with aspirin (E) does not address acute occlusion. Mechanical thrombectomy has shown benefit up to 24 hours in selected patients and is not contraindicated by therapeutic anticoagulation if the procedure can be performed safely.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Correct best answer. The vignette presents a clear case of acute ischemic stroke involving a Large Vessel Occlusion (LVO) of the Left MCA M1 segment. The patient presents at 4 hours, which is within the standard 6-hour window for endovascular therapy. The key discriminating factor is the patient's supratherapeutic INR of 2.8 due to warfarin. According to AHA/ASA guidelines, intravenous alteplase (tPA) is contraindicated in patients with an INR > 1.7, ruling out Option A. Mechanical thrombectomy (Option B) is the Class I recommendation for eligible patients with LVO and is not contraindicated by therapeutic anticoagulation, making it the definitive best answer. Option C (heparin) is not indicated for acute reperfusion and increases hemorrhagic conversion risk. Option D (intra-arterial thrombolysis) is generally reserved for salvage therapy and carries significant bleeding risk given the INR. Option E fails to address the acute occlusion. The item is medically accurate, logically sound, and aligns perfectly with current stroke management standards for anticoagulated patients. No changes are needed.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Correct best answer. The vignette presents a clear case of acute ischemic stroke involving a Large Vessel Occlusion (LVO) of the Left MCA M1 segment. The patient presents at 4 hours, which is within the standard 6-hour window for endovascular therapy. The key discriminating factor is the patient's supratherapeutic INR of 2.8 due to warfarin. According to AHA/ASA guidelines, intravenous alteplase (tPA) is contraindicated in patients with an INR > 1.7, ruling out Option A. Mechanical thrombectomy (Option B) is the Class I recommendation for eligible patients with LVO and is not contraindicated by therapeutic anticoagulation, making it the definitive best answer. Option C (heparin) is not indicated for acute reperfusion and increases hemorrhagic conversion risk. Option D (intra-arterial thrombolysis) is generally reserved for salvage therapy and carries significant bleeding risk given the INR. Option E fails to address the acute occlusion. The item is medically accurate, logically sound, and aligns perfectly with current stroke management standards for anticoagulated patients. No changes are needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-006", "question": "A 29-year-old woman presents with 6 months of progressive dyspnea and palpitations. Echocardiogram shows severe pulmonary hypertension (RVSP 85 mmHg) with right ventricular dilation but normal left heart function. Right heart catheterization confirms pre-capillary pulmonary hypertension (mPAP 48 mmHg, PAWP 10 mmHg). High-resolution CT shows mosaic attenuation and enlarged central pulmonary arteries. Ventilation-perfusion scan reveals multiple segmental perfusion defects. Which of the following is the definitive diagnostic test?", "options": ["Pulmonary angiogram", "CT pulmonary angiogram", "Genetic testing for BMPR2 mutation", "Lung biopsy", "Exercise right heart catheterization"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for chronic thromboembolic pulmonary hypertension (CTEPH). While V/Q scan is the screening test, pulmonary angiography remains the gold standard for defining surgical accessibility and planning pulmonary endarterectomy. CT pulmonary angiography (B) provides anatomical detail but has lower sensitivity for chronic thromboembolic material. Genetic testing (C) is for heritable pulmonary arterial hypertension, not CTEPH. Lung biopsy (D) is contraindicated in severe pulmonary hypertension. Exercise catheterization (E) may confirm exercise-induced PH but doesn't diagnose CTEPH. Pulmonary angiography is essential for determining operability in CTEPH.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette presents a classic case of Chronic Thromboembolic Pulmonary Hypertension (CTEPH), evidenced by severe pre-capillary pulmonary hypertension, mosaic attenuation on CT, and mismatched segmental perfusion defects on V/Q scan. The question asks for the 'definitive diagnostic test.' While CT pulmonary angiography (Option B) is the widely used first-line modality for confirmation, invasive Pulmonary Angiography (Option A) remains the gold standard (reference standard) for characterizing the pulmonary vasculature and determining surgical operability (pulmonary endarterectomy vs. balloon angioplasty). In board exam contexts, 'definitive' typically maps to the gold standard, distinguishing A from B. Genetic testing (C) is for PAH, not CTEPH. Lung biopsy (D) is contraindicated. Exercise RHC (E) is not indicated given the resting severity. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette presents a classic case of Chronic Thromboembolic Pulmonary Hypertension (CTEPH), evidenced by severe pre-capillary pulmonary hypertension, mosaic attenuation on CT, and mismatched segmental perfusion defects on V/Q scan. The question asks for the 'definitive diagnostic test.' While CT pulmonary angiography (Option B) is the widely used first-line modality for confirmation, invasive Pulmonary Angiography (Option A) remains the gold standard (reference standard) for characterizing the pulmonary vasculature and determining surgical operability (pulmonary endarterectomy vs. balloon angioplasty). In board exam contexts, 'definitive' typically maps to the gold standard, distinguishing A from B. Genetic testing (C) is for PAH, not CTEPH. Lung biopsy (D) is contraindicated. Exercise RHC (E) is not indicated given the resting severity. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-007", "question": "A 63-year-old man with diabetes and peripheral arterial disease presents with 2 hours of acute, painless monocular vision loss in the right eye. Visual acuity is hand motion only. Funduscopy reveals a pale retina with cherry-red spot and boxcarring of retinal vessels. Carotid duplex shows 90% stenosis of the right internal carotid artery. Which of the following is the most urgent intervention?", "options": ["Intravenous tissue plasminogen activator", "Anterior chamber paracentesis", "Immediate carotid endarterectomy", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization"], "answer": "E", "answer_index": 4, "explanation": "This describes central retinal artery occlusion (CRAO) with cherry-red spot and boxcarring, indicating acute ischemia. Intra-arterial thrombolysis via selective ophthalmic artery catheterization within 6-12 hours may restore vision in CRAO, though evidence is limited. IV tPA (A) is not standard for CRAO. Anterior chamber paracentesis (B) is historical but ineffective. Carotid endarterectomy (C) addresses the source but not the acute occlusion. Hyperbaric oxygen (D) has limited evidence. Given the time window and severity, selective intra-arterial thrombolysis offers the best chance for visual recovery in this acute setting.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed). Verdict: Miskeyed. The vignette describes a patient with acute Central Retinal Artery Occlusion (CRAO) presenting within the therapeutic window (2 hours). The keyed answer, Intra-arterial thrombolysis (Option E), is medically inaccurate based on the landmark EAGLE trial (2010), which demonstrated no benefit of intra-arterial thrombolysis over conservative care and found higher rates of adverse events. Consequently, Option E is not the standard of care and is often discouraged. In contrast, current guidelines (e.g., AHA 2021 Scientific Statement) suggest that Intravenous tPA (Option A) is the most reasonable reperfusion therapy if administered within 4.5 hours, analogous to acute ischemic stroke management. Option B (Paracentesis) is a common immediate bedside temporizing measure but has limited efficacy. Option C (CEA) is crucial for secondary prevention given the 90% stenosis but does not treat the acute retinal ischemia. The item is miskeyed because it selects a therapy proven ineffective in RCTs (E) over a guideline-supported alternative (A). Minimal fix: Change the key to A or replace the reperfusion options with a less controversial management step.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. The vignette describes a patient with acute Central Retinal Artery Occlusion (CRAO) presenting within the therapeutic window (2 hours). The keyed answer, Intra-arterial thrombolysis (Option E), is medically inaccurate based on the landmark EAGLE trial (2010), which demonstrated no benefit of intra-arterial thrombolysis over conservative care and found higher rates of adverse events. Consequently, Option E is not the standard of care and is often discouraged. In contrast, current guidelines (e.g., AHA 2021 Scientific Statement) suggest that Intravenous tPA (Option A) is the most reasonable reperfusion therapy if administered within 4.5 hours, analogous to acute ischemic stroke management. Option B (Paracentesis) is a common immediate bedside temporizing measure but has limited efficacy. Option C (CEA) is crucial for secondary prevention given the 90% stenosis but does not treat the acute retinal ischemia. The item is miskeyed because it selects a therapy proven ineffective in RCTs (E) over a guideline-supported alternative (A). Minimal fix: Change the key to A or replace the reperfusion options with a less controversial management step.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-008", "question": "A 38-year-old woman with history of mitral valve prolapse presents with 3 weeks of daily fevers, night sweats, and new-onset diastolic murmur. Blood cultures are negative after 72 hours. Transthoracic echocardiogram shows a 12mm mobile vegetation on the anterior mitral leaflet with severe mitral regurgitation. Which of the following organisms is most likely responsible?", "options": ["Streptococcus gallolyticus", "Coxiella burnetii", "Bartonella henselae", "Tropheryma whipplei", "Abiotrophia defectiva"], "answer": "C", "answer_index": 2, "explanation": "This presentation suggests culture-negative endocarditis in a patient with pre-existing mitral valve disease. Bartonella henselae is the most common cause of culture-negative endocarditis in patients with valve abnormalities, particularly associated with negative blood cultures, subacute presentation, and large vegetations. Coxiella burnetii (B) typically causes Q fever endocarditis with exposure history. Streptococcus gallolyticus (A) is culture-positive and associated with colorectal pathology. Tropheryma whipplei (D) causes Whipple's disease with systemic symptoms. Abiotrophia (E) is nutritionally variant but usually culture-positive. Bartonella requires serology or PCR for diagnosis and responds to specific antibiotic regimens.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). The vignette describes a case of culture-negative endocarditis (CNE). Streptococcus gallolyticus (A) typically grows readily in standard blood cultures. Abiotrophia (E) is fastidious but usually grows within 72 hours in modern systems or is suspected with gram stain findings. Tropheryma whipplei (D) is a very rare cause associated with specific systemic symptoms (arthralgias, GI). The primary discrimination is between Coxiella burnetii (B) and Bartonella henselae (C), the two most common causes of CNE. The key discriminating factor provided is the echocardiographic finding. Coxiella burnetii endocarditis is classically associated with small or absent vegetations (often not visible on TTE). In contrast, Bartonella species frequently cause large, mobile vegetations (often >10mm). The presence of a 12mm vegetation makes Bartonella the distinct best answer despite the lack of specific exposure history (e.g., cats vs. livestock). The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). The vignette describes a case of culture-negative endocarditis (CNE). Streptococcus gallolyticus (A) typically grows readily in standard blood cultures. Abiotrophia (E) is fastidious but usually grows within 72 hours in modern systems or is suspected with gram stain findings. Tropheryma whipplei (D) is a very rare cause associated with specific systemic symptoms (arthralgias, GI). The primary discrimination is between Coxiella burnetii (B) and Bartonella henselae (C), the two most common causes of CNE. The key discriminating factor provided is the echocardiographic finding. Coxiella burnetii endocarditis is classically associated with small or absent vegetations (often not visible on TTE). In contrast, Bartonella species frequently cause large, mobile vegetations (often >10mm). The presence of a 12mm vegetation makes Bartonella the distinct best answer despite the lack of specific exposure history (e.g., cats vs. livestock). The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-009", "question": "A 52-year-old woman with rheumatoid arthritis on methotrexate presents with progressive dyspnea and dry cough. High-resolution CT shows extensive ground-glass opacities with centrilobular nodules and tree-in-bud pattern predominantly in upper lobes. Bronchoscopy with transbronchial biopsy reveals non-necrotizing granulomas with multinucleated giant cells. Which of the following is the most likely diagnosis?", "options": ["Methotrexate pneumonitis", "Rheumatoid arthritis-associated interstitial lung disease", "Mycobacterium avium complex infection", "Sarcoidosis", "Hypersensitivity pneumonitis"], "answer": "C", "answer_index": 2, "explanation": "The combination of upper lobe predominance, tree-in-bud pattern, and non-necrotizing granulomas in an immunocompromised patient on methotrexate is classic for nontuberculous mycobacterial infection, particularly MAC. Methotrexate pneumonitis (A) typically shows diffuse alveolar damage pattern. RA-ILD (B) usually shows UIP or NSIP patterns. Sarcoidosis (D) shows perilymphatic nodules and hilar adenopathy. Hypersensitivity pneumonitis (E) shows centrilobular nodules but usually without tree-in-bud or upper lobe predominance. Immunosuppressed patients on methotrexate are at increased risk for NTM infections, which can mimic granulomatous diseases.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict on keyed answer: Correct best. The clinical vignette describes an immunocompromised patient (RA on methotrexate) with upper lobe-predominant lung disease. The critical discriminating finding is the 'tree-in-bud' pattern on HRCT. In board-exam contexts, tree-in-bud represents bronchiolar impaction and is highly specific for infection (bacterial, mycobacterial) or aspiration, effectively ruling out pure interstitial lung diseases like Sarcoidosis (perilymphatic nodules), Hypersensitivity Pneumonitis (centrilobular ground-glass nodules without impaction), and RA-ILD. While Sarcoidosis and HP are characterized by non-necrotizing granulomas, the imaging pattern does not fit. Nontuberculous mycobacterial (NTM) infections like MAC are common in patients on methotrexate, classically present with tree-in-bud and nodules, and can show granulomas (which may be non-necrotizing, though often necrotizing, the imaging finding takes precedence here). Thus, Option C is the only answer that accounts for the infectious bronchiolitis pattern in this risk group.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict on keyed answer: Correct best. The clinical vignette describes an immunocompromised patient (RA on methotrexate) with upper lobe-predominant lung disease. The critical discriminating finding is the 'tree-in-bud' pattern on HRCT. In board-exam contexts, tree-in-bud represents bronchiolar impaction and is highly specific for infection (bacterial, mycobacterial) or aspiration, effectively ruling out pure interstitial lung diseases like Sarcoidosis (perilymphatic nodules), Hypersensitivity Pneumonitis (centrilobular ground-glass nodules without impaction), and RA-ILD. While Sarcoidosis and HP are characterized by non-necrotizing granulomas, the imaging pattern does not fit. Nontuberculous mycobacterial (NTM) infections like MAC are common in patients on methotrexate, classically present with tree-in-bud and nodules, and can show granulomas (which may be non-necrotizing, though often necrotizing, the imaging finding takes precedence here). Thus, Option C is the only answer that accounts for the infectious bronchiolitis pattern in this risk group.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-010", "question": "A 44-year-old woman presents with 8 months of progressive proximal muscle weakness, heliotrope rash, and Gottron's papules. Muscle biopsy shows perfascicular atrophy and MAC deposition on capillaries. She tests positive for anti-MDA5 antibodies. Which of the following complications carries the highest immediate mortality risk?", "options": ["Aspiration pneumonia", "Cardiac conduction abnormalities", "Rapidly progressive interstitial lung disease", "Malignancy-associated deterioration", "Calcinosis universalis"], "answer": "C", "answer_index": 2, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is strongly associated with rapidly progressive interstitial lung disease (RP-ILD), which has mortality exceeding 50% within 6 months despite treatment. This subtype shows characteristic skin findings but often minimal muscle involvement, with MAC deposition on capillaries. While aspiration (A) and cardiac issues (B) occur in myositis, RP-ILD is the most lethal complication in anti-MDA5 patients. Malignancy risk (D) is lower with anti-MDA5 than with anti-TIF1γ. Calcinosis (E) is chronic but not immediately life-threatening. Early recognition and aggressive immunosuppression for RP-ILD are critical in anti-MDA5 dermatomyositis.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item describes a classic presentation of dermatomyositis (DM) confirmed by pathognomonic biopsy findings (perifascicular atrophy) and specific serology (anti-MDA5). The question tests the specific clinical association of the anti-MDA5 antibody. Anti-MDA5 is strongly linked to clinically amyopathic DM (though muscle involvement can occur, as in this case) and, most critically, Rapidly Progressive Interstitial Lung Disease (RP-ILD). RP-ILD is the leading cause of early mortality in this subgroup, often resistant to therapy. While aspiration (A) and cardiac issues (B) are complications of DM, they are not the specific hallmark mortality risk of the anti-MDA5 phenotype. Malignancy (D) is more strongly associated with anti-TIF1-gamma and anti-NXP2 antibodies; anti-MDA5 actually carries a lower malignancy risk relative to other DM subtypes. Calcinosis (E) is a chronic complication, often linked to anti-NXP2. The item is medically accurate, logically sound, and the key (C) is the undisputed best answer based on current rheumatology literature.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item describes a classic presentation of dermatomyositis (DM) confirmed by pathognomonic biopsy findings (perifascicular atrophy) and specific serology (anti-MDA5). The question tests the specific clinical association of the anti-MDA5 antibody. Anti-MDA5 is strongly linked to clinically amyopathic DM (though muscle involvement can occur, as in this case) and, most critically, Rapidly Progressive Interstitial Lung Disease (RP-ILD). RP-ILD is the leading cause of early mortality in this subgroup, often resistant to therapy. While aspiration (A) and cardiac issues (B) are complications of DM, they are not the specific hallmark mortality risk of the anti-MDA5 phenotype. Malignancy (D) is more strongly associated with anti-TIF1-gamma and anti-NXP2 antibodies; anti-MDA5 actually carries a lower malignancy risk relative to other DM subtypes. Calcinosis (E) is a chronic complication, often linked to anti-NXP2. The item is medically accurate, logically sound, and the key (C) is the undisputed best answer based on current rheumatology literature.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]